(Q36528210)

14 August 2017

The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo (English)

1 reference

14 August 2017

Edward Htun van der Horst

1

1 reference

14 August 2017

Brendon T Frank

2

1 reference

14 August 2017

Lawrence Chinn

3

1 reference

14 August 2017

Angela Coxon

4

1 reference

14 August 2017

Shyun Li

5

1 reference

14 August 2017

Fanny Polesso

6

1 reference

14 August 2017

Anthony Slavin

7

1 reference

14 August 2017

Astrid Ruefli-Brasse

8

1 reference

14 August 2017

Holger Wesche

9

1 reference

14 August 2017

1 April 2008

1 reference

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

4

1 reference

14 August 2017

340-347

1 reference

Midkine as a novel target for antibody therapy in osteosarcoma

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Angiogenesis as a therapeutic target

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: novel heregulin/HER3-stimulated signaling pathway in glioma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Vascular endothelial growth factor: basic science and clinical progress

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Vascular endothelial growth factor as a target for anticancer therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Midkine and pleiotrophin in neural development and cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Angiogenesis and apoptosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Serum midkine levels are increased in patients with various types of carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2288540

Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis

21 September 2018

1 reference

12 December 2020

Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma

1 reference

12 December 2020

An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis

1 reference

12 December 2020

Angiogenesis assays in the chick CAM

1 reference

12 December 2020

Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis

1 reference

12 December 2020

Identifiers

DOI

10.1593/NEO.07820

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

18392135

1 reference